STAT3 and gastric adenocarcinoma: Z M Bai and colleagues reported a prominent decrease in hsa-miR-328-3p levels in gastric adenocarcinoma tissues, along with an increase in the levels of STAT3 and its downstream effectors, including MMP2, CCND1, and COX2.